Italy
· Delayed Price · Currency is EUR Halozyme Therapeutics Statistics
Total Valuation
BIT:1HALO has a market cap or net worth of EUR 5.39 billion. The enterprise value is 6.10 billion.
| Market Cap | 5.39B |
| Enterprise Value | 6.10B |
Important Dates
The last earnings date was Tuesday, May 6, 2025.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 123.22M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.34% |
| Shares Change (QoQ) | -1.81% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 121.83M |
Valuation Ratios
The trailing PE ratio is 12.01 and the forward PE ratio is 8.15.
| PE Ratio | 12.01 |
| Forward PE | 8.15 |
| PS Ratio | 5.38 |
| PB Ratio | 12.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.76 |
| P/OCF Ratio | 11.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.00, with an EV/FCF ratio of 13.29.
| EV / Earnings | 13.58 |
| EV / Sales | 6.29 |
| EV / EBITDA | 10.00 |
| EV / EBIT | 11.42 |
| EV / FCF | 13.29 |
Financial Position
The company has a current ratio of 8.39, with a Debt / Equity ratio of 3.19.
| Current Ratio | 8.39 |
| Quick Ratio | 7.00 |
| Debt / Equity | 3.19 |
| Debt / EBITDA | 2.25 |
| Debt / FCF | 3.10 |
| Interest Coverage | 32.99 |
Financial Efficiency
Return on equity (ROE) is 147.06% and return on invested capital (ROIC) is 20.02%.
| Return on Equity (ROE) | 147.06% |
| Return on Assets (ROA) | 18.49% |
| Return on Invested Capital (ROIC) | 20.02% |
| Return on Capital Employed (ROCE) | 29.20% |
| Revenue Per Employee | 2.87M |
| Profits Per Employee | 1.28M |
| Employee Count | 350 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 160 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.54 |
Income Statement
In the last 12 months, BIT:1HALO had revenue of EUR 1.00 billion and earned 449.06 million in profits. Earnings per share was 3.48.
| Revenue | 1.00B |
| Gross Profit | 764.11M |
| Operating Income | 552.78M |
| Pretax Income | 559.68M |
| Net Income | 449.06M |
| EBITDA | 622.87M |
| EBIT | 552.78M |
| Earnings Per Share (EPS) | 3.48 |
Balance Sheet
The company has 691.98 million in cash and 1.42 billion in debt, giving a net cash position of -729.90 million.
| Cash & Cash Equivalents | 691.98M |
| Total Debt | 1.42B |
| Net Cash | -729.90M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 446.20M |
| Book Value Per Share | 3.62 |
| Working Capital | 1.03B |
Cash Flow
In the last 12 months, operating cash flow was 466.17 million and capital expenditures -7.50 million, giving a free cash flow of 458.67 million.
| Operating Cash Flow | 466.17M |
| Capital Expenditures | -7.50M |
| Free Cash Flow | 458.67M |
| FCF Per Share | n/a |
Margins
Gross margin is 76.17%, with operating and profit margins of 55.10% and 44.76%.
| Gross Margin | 76.17% |
| Operating Margin | 55.10% |
| Pretax Margin | 55.79% |
| Profit Margin | 44.76% |
| EBITDA Margin | 62.09% |
| EBIT Margin | 55.10% |
| FCF Margin | 45.72% |
Dividends & Yields
BIT:1HALO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.34% |
| Shareholder Yield | 2.34% |
| Earnings Yield | 8.33% |
| FCF Yield | 8.51% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIT:1HALO has an Altman Z-Score of 4.63.
| Altman Z-Score | 4.63 |
| Piotroski F-Score | n/a |